KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) FCF Margin: 2009-2024

Historic FCF Margin for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to 4.53%.

  • Teva Pharmaceutical Industries' FCF Margin fell 738.00% to 5.20% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.45%, marking a year-over-year decrease of 471.00%. This contributed to the annual value of 4.53% for FY2024, which is 79.00% down from last year.
  • According to the latest figures from FY2024, Teva Pharmaceutical Industries' FCF Margin is 4.53%, which was down 14.80% from 5.31% recorded in FY2023.
  • In the past 5 years, Teva Pharmaceutical Industries' FCF Margin ranged from a high of 6.98% in FY2022 and a low of 1.49% during FY2021.
  • In the last 3 years, Teva Pharmaceutical Industries' FCF Margin had a median value of 5.31% in 2023 and averaged 5.61%.
  • Its FCF Margin has fluctuated over the past 5 years, first plummeted by 234bps in 2021, then surged by 550bps in 2022.
  • Yearly analysis of 5 years shows Teva Pharmaceutical Industries' FCF Margin stood at 3.83% in 2020, then crashed by 234bps to 1.49% in 2021, then spiked by 550bps to 6.98% in 2022, then crashed by 167bps to 5.31% in 2023, then tumbled by 79bps to 4.53% in 2024.